Targeting ubiquitin signaling vulnerabilities in KEAP1-inactivated lung cancer
Varun Jayeshkumar Shah·Ivan Dikic·Koraljka Husnjak·Markus E. Diefenbacher·Manuel Kaulich·Rubina Kazi·Igor Mačinković·Dmitry Namgaladze·Martin Wegner·Mathias T. Rosenfeldt·Cristian Prieto-Garcia·Bianka Bohnacker·Oliver Hartmann·Viktoria von Heyl zu Herrnsheim·Amin Wanli
Lung cancer cells rely on protein homeostasis regulators, particularly the ubiquitin-proteasome system (UPS), to sustain malignancy. Genetic alterations in UPS components, such as E3 ubiquitin ligases (E3s) and deubiquitinating enzymes (DUBs), are common and create context-dependent therapeutic dependencies. To investigate how these genetic alterations drive tumor formation, we conducted CRISPR screens on metabolically stressed murine lung cancer models and identified specific cancer dependencie
